TCGA,X.x,participant,X.y,project,tss,disease,bcr,sample,vial,portion,analyte,plate,center,center.typeTCGA,A6,2675,12,TCGA,Christiana Healthcare,Colon adenocarcinoma,IGC,Primary solid Tumor,A,2,Total RNA,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,A6,2675,11,TCGA,Christiana Healthcare,Colon adenocarcinoma,IGC,Primary solid Tumor,A,2,Total RNA,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AA,3489,90,TCGA,Indivumed,Colon adenocarcinoma,IGC,Primary solid Tumor,A,21,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AA,3489,91,TCGA,Indivumed,Colon adenocarcinoma,IGC,Primary solid Tumor,A,21,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AA,3496,93,TCGA,Indivumed,Colon adenocarcinoma,IGC,Primary solid Tumor,A,21,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AA,3496,92,TCGA,Indivumed,Colon adenocarcinoma,IGC,Primary solid Tumor,A,21,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AA,3511,94,TCGA,Indivumed,Colon adenocarcinoma,IGC,Primary solid Tumor,A,21,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AA,3511,95,TCGA,Indivumed,Colon adenocarcinoma,IGC,Primary solid Tumor,A,21,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AA,3655,102,TCGA,Indivumed,Colon adenocarcinoma,IGC,Primary solid Tumor,A,2,Total RNA,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AA,3655,103,TCGA,Indivumed,Colon adenocarcinoma,IGC,Primary solid Tumor,A,2,Total RNA,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AA,3660,105,TCGA,Indivumed,Colon adenocarcinoma,IGC,Primary solid Tumor,A,1,Total RNA,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AA,3660,104,TCGA,Indivumed,Colon adenocarcinoma,IGC,Primary solid Tumor,A,1,Total RNA,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AA,3662,107,TCGA,Indivumed,Colon adenocarcinoma,IGC,Primary solid Tumor,A,1,Total RNA,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AA,3662,106,TCGA,Indivumed,Colon adenocarcinoma,IGC,Primary solid Tumor,A,1,Total RNA,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AA,3663,108,TCGA,Indivumed,Colon adenocarcinoma,IGC,Primary solid Tumor,A,1,Total RNA,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AA,3663,109,TCGA,Indivumed,Colon adenocarcinoma,IGC,Primary solid Tumor,A,1,Total RNA,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AA,3697,111,TCGA,Indivumed,Colon adenocarcinoma,IGC,Primary solid Tumor,A,1,Total RNA,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AA,3697,110,TCGA,Indivumed,Colon adenocarcinoma,IGC,Primary solid Tumor,A,1,Total RNA,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AA,3712,112,TCGA,Indivumed,Colon adenocarcinoma,IGC,Primary solid Tumor,A,21,mirVana RNA (Allprep DNA) produced by hybrid protocol,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AA,3712,113,TCGA,Indivumed,Colon adenocarcinoma,IGC,Primary solid Tumor,A,21,mirVana RNA (Allprep DNA) produced by hybrid protocol,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AA,3713,115,TCGA,Indivumed,Colon adenocarcinoma,IGC,Primary solid Tumor,A,21,mirVana RNA (Allprep DNA) produced by hybrid protocol,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AA,3713,114,TCGA,Indivumed,Colon adenocarcinoma,IGC,Primary solid Tumor,A,21,mirVana RNA (Allprep DNA) produced by hybrid protocol,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AU,3779,145,TCGA,St. Joseph's Medical Center-(MD),Colon adenocarcinoma,IGC,Primary solid Tumor,A,1,Total RNA,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AU,3779,144,TCGA,St. Joseph's Medical Center-(MD),Colon adenocarcinoma,IGC,Primary solid Tumor,A,1,Total RNA,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,A6,4105,21,TCGA,Christiana Healthcare,Colon adenocarcinoma,IGC,Primary solid Tumor,A,2,Total RNA,1773,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,A6,4105,22,TCGA,Christiana Healthcare,Colon adenocarcinoma,IGC,Primary solid Tumor,A,2,Total RNA,1773,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AZ,4323,161,TCGA,University of Pittsburgh,Colon adenocarcinoma,IGC,Primary solid Tumor,A,21,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AZ,4323,160,TCGA,University of Pittsburgh,Colon adenocarcinoma,IGC,Primary solid Tumor,A,21,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AZ,4616,162,TCGA,University of Pittsburgh,Colon adenocarcinoma,IGC,Primary solid Tumor,A,21,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AZ,4616,163,TCGA,University of Pittsburgh,Colon adenocarcinoma,IGC,Primary solid Tumor,A,21,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CM,4743,230,TCGA,MSKCC,Colon adenocarcinoma,IGC,Primary solid Tumor,A,1,Total RNA,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CM,4743,231,TCGA,MSKCC,Colon adenocarcinoma,IGC,Primary solid Tumor,A,1,Total RNA,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CM,4751,232,TCGA,MSKCC,Colon adenocarcinoma,IGC,Primary solid Tumor,A,2,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CM,4751,233,TCGA,MSKCC,Colon adenocarcinoma,IGC,Primary solid Tumor,A,2,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CK,4947,205,TCGA,Harvard,Colon adenocarcinoma,IGC,Primary solid Tumor,B,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CK,4947,204,TCGA,Harvard,Colon adenocarcinoma,IGC,Primary solid Tumor,B,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CK,4948,206,TCGA,Harvard,Colon adenocarcinoma,IGC,Primary solid Tumor,B,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CK,4948,207,TCGA,Harvard,Colon adenocarcinoma,IGC,Primary solid Tumor,B,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CK,4950,209,TCGA,Harvard,Colon adenocarcinoma,IGC,Primary solid Tumor,A,1,Total RNA,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CK,4950,208,TCGA,Harvard,Colon adenocarcinoma,IGC,Primary solid Tumor,A,1,Total RNA,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CK,4952,210,TCGA,Harvard,Colon adenocarcinoma,IGC,Primary solid Tumor,A,1,Total RNA,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CK,4952,211,TCGA,Harvard,Colon adenocarcinoma,IGC,Primary solid Tumor,A,1,Total RNA,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CA,5254,187,TCGA,ILSBio,Colon adenocarcinoma,IGC,Primary solid Tumor,A,21,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CA,5254,186,TCGA,ILSBio,Colon adenocarcinoma,IGC,Primary solid Tumor,A,21,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CA,5255,188,TCGA,ILSBio,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CA,5255,189,TCGA,ILSBio,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CM,5344,234,TCGA,MSKCC,Colon adenocarcinoma,IGC,Primary solid Tumor,A,21,mirVana RNA (Allprep DNA) produced by hybrid protocol,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CM,5344,235,TCGA,MSKCC,Colon adenocarcinoma,IGC,Primary solid Tumor,A,21,mirVana RNA (Allprep DNA) produced by hybrid protocol,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CM,5348,236,TCGA,MSKCC,Colon adenocarcinoma,IGC,Primary solid Tumor,A,21,mirVana RNA (Allprep DNA) produced by hybrid protocol,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CM,5348,237,TCGA,MSKCC,Colon adenocarcinoma,IGC,Primary solid Tumor,A,21,mirVana RNA (Allprep DNA) produced by hybrid protocol,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CM,5349,238,TCGA,MSKCC,Colon adenocarcinoma,IGC,Primary solid Tumor,A,21,mirVana RNA (Allprep DNA) produced by hybrid protocol,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CM,5349,239,TCGA,MSKCC,Colon adenocarcinoma,IGC,Primary solid Tumor,A,21,mirVana RNA (Allprep DNA) produced by hybrid protocol,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AZ,5403,165,TCGA,University of Pittsburgh,Colon adenocarcinoma,IGC,Primary solid Tumor,A,1,Total RNA,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AZ,5403,164,TCGA,University of Pittsburgh,Colon adenocarcinoma,IGC,Primary solid Tumor,A,1,Total RNA,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AZ,5407,166,TCGA,University of Pittsburgh,Colon adenocarcinoma,IGC,Primary solid Tumor,A,1,Total RNA,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AZ,5407,167,TCGA,University of Pittsburgh,Colon adenocarcinoma,IGC,Primary solid Tumor,A,1,Total RNA,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,D5,5537,290,TCGA,Greater Poland Cancer Center,Colon adenocarcinoma,IGC,Primary solid Tumor,A,21,mirVana RNA (Allprep DNA) produced by hybrid protocol,1927,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,D5,5537,291,TCGA,Greater Poland Cancer Center,Colon adenocarcinoma,IGC,Primary solid Tumor,A,21,mirVana RNA (Allprep DNA) produced by hybrid protocol,1927,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,D5,5538,292,TCGA,Greater Poland Cancer Center,Colon adenocarcinoma,IGC,Primary solid Tumor,A,1,Total RNA,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,D5,5538,293,TCGA,Greater Poland Cancer Center,Colon adenocarcinoma,IGC,Primary solid Tumor,A,1,Total RNA,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,D5,5539,295,TCGA,Greater Poland Cancer Center,Colon adenocarcinoma,IGC,Primary solid Tumor,A,1,Total RNA,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,D5,5539,294,TCGA,Greater Poland Cancer Center,Colon adenocarcinoma,IGC,Primary solid Tumor,A,1,Total RNA,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,D5,5540,296,TCGA,Greater Poland Cancer Center,Colon adenocarcinoma,IGC,Primary solid Tumor,A,1,Total RNA,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,D5,5540,297,TCGA,Greater Poland Cancer Center,Colon adenocarcinoma,IGC,Primary solid Tumor,A,1,Total RNA,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,D5,5541,299,TCGA,Greater Poland Cancer Center,Colon adenocarcinoma,IGC,Primary solid Tumor,A,1,Total RNA,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,D5,5541,298,TCGA,Greater Poland Cancer Center,Colon adenocarcinoma,IGC,Primary solid Tumor,A,1,Total RNA,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AY,5543,148,TCGA,UNC,Colon adenocarcinoma,IGC,Primary solid Tumor,A,1,Total RNA,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AY,5543,149,TCGA,UNC,Colon adenocarcinoma,IGC,Primary solid Tumor,A,1,Total RNA,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,A6,5656,24,TCGA,Christiana Healthcare,Colon adenocarcinoma,IGC,Primary solid Tumor,A,21,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,A6,5656,25,TCGA,Christiana Healthcare,Colon adenocarcinoma,IGC,Primary solid Tumor,A,21,mirVana RNA (Allprep DNA) produced by hybrid protocol,A279,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,A6,5656,26,TCGA,Christiana Healthcare,Colon adenocarcinoma,IGC,Primary solid Tumor,B,2,RNA,A27D,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,A6,5656,23,TCGA,Christiana Healthcare,Colon adenocarcinoma,IGC,Primary solid Tumor,A,21,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,A6,5657,27,TCGA,Christiana Healthcare,Colon adenocarcinoma,IGC,Primary solid Tumor,A,1,Total RNA,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,A6,5657,28,TCGA,Christiana Healthcare,Colon adenocarcinoma,IGC,Primary solid Tumor,A,1,Total RNA,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,A6,5659,29,TCGA,Christiana Healthcare,Colon adenocarcinoma,IGC,Primary solid Tumor,A,1,Total RNA,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,A6,5659,30,TCGA,Christiana Healthcare,Colon adenocarcinoma,IGC,Primary solid Tumor,A,1,Total RNA,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,A6,5660,31,TCGA,Christiana Healthcare,Colon adenocarcinoma,IGC,Primary solid Tumor,A,1,Total RNA,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,A6,5660,32,TCGA,Christiana Healthcare,Colon adenocarcinoma,IGC,Primary solid Tumor,A,1,Total RNA,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,A6,5661,33,TCGA,Christiana Healthcare,Colon adenocarcinoma,IGC,Primary solid Tumor,A,1,Total RNA,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,A6,5661,35,TCGA,Christiana Healthcare,Colon adenocarcinoma,IGC,Primary solid Tumor,B,5,RNA,2303,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,A6,5661,36,TCGA,Christiana Healthcare,Colon adenocarcinoma,IGC,Primary solid Tumor,B,5,RNA,2303,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,A6,5661,34,TCGA,Christiana Healthcare,Colon adenocarcinoma,IGC,Primary solid Tumor,A,1,Total RNA,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,A6,5662,37,TCGA,Christiana Healthcare,Colon adenocarcinoma,IGC,Primary solid Tumor,A,1,Total RNA,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,A6,5662,38,TCGA,Christiana Healthcare,Colon adenocarcinoma,IGC,Primary solid Tumor,A,1,Total RNA,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,A6,5664,40,TCGA,Christiana Healthcare,Colon adenocarcinoma,IGC,Primary solid Tumor,A,21,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,A6,5664,39,TCGA,Christiana Healthcare,Colon adenocarcinoma,IGC,Primary solid Tumor,A,21,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,A6,5665,41,TCGA,Christiana Healthcare,Colon adenocarcinoma,IGC,Primary solid Tumor,A,1,Total RNA,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,A6,5665,42,TCGA,Christiana Healthcare,Colon adenocarcinoma,IGC,Primary solid Tumor,A,1,Total RNA,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,A6,5665,44,TCGA,Christiana Healthcare,Colon adenocarcinoma,IGC,Primary solid Tumor,B,3,RNA,2303,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,A6,5665,43,TCGA,Christiana Healthcare,Colon adenocarcinoma,IGC,Primary solid Tumor,B,3,RNA,2303,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,A6,5666,45,TCGA,Christiana Healthcare,Colon adenocarcinoma,IGC,Primary solid Tumor,A,1,Total RNA,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,A6,5666,46,TCGA,Christiana Healthcare,Colon adenocarcinoma,IGC,Primary solid Tumor,A,1,Total RNA,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,A6,5667,48,TCGA,Christiana Healthcare,Colon adenocarcinoma,IGC,Primary solid Tumor,A,21,mirVana RNA (Allprep DNA) produced by hybrid protocol,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,A6,5667,47,TCGA,Christiana Healthcare,Colon adenocarcinoma,IGC,Primary solid Tumor,A,21,mirVana RNA (Allprep DNA) produced by hybrid protocol,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CA,5796,190,TCGA,ILSBio,Colon adenocarcinoma,IGC,Primary solid Tumor,A,1,Total RNA,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CA,5796,191,TCGA,ILSBio,Colon adenocarcinoma,IGC,Primary solid Tumor,A,1,Total RNA,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CA,5797,192,TCGA,ILSBio,Colon adenocarcinoma,IGC,Primary solid Tumor,A,1,Total RNA,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CA,5797,193,TCGA,ILSBio,Colon adenocarcinoma,IGC,Primary solid Tumor,A,1,Total RNA,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AM,5820,141,TCGA,Cureline,Colon adenocarcinoma,IGC,Primary solid Tumor,A,1,Total RNA,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AM,5820,140,TCGA,Cureline,Colon adenocarcinoma,IGC,Primary solid Tumor,A,1,Total RNA,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AM,5821,142,TCGA,Cureline,Colon adenocarcinoma,IGC,Primary solid Tumor,A,1,Total RNA,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AM,5821,143,TCGA,Cureline,Colon adenocarcinoma,IGC,Primary solid Tumor,A,1,Total RNA,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CM,5860,241,TCGA,MSKCC,Colon adenocarcinoma,IGC,Primary solid Tumor,A,1,Total RNA,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CM,5860,240,TCGA,MSKCC,Colon adenocarcinoma,IGC,Primary solid Tumor,A,1,Total RNA,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CM,5861,242,TCGA,MSKCC,Colon adenocarcinoma,IGC,Primary solid Tumor,A,1,Total RNA,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CM,5861,243,TCGA,MSKCC,Colon adenocarcinoma,IGC,Primary solid Tumor,A,1,Total RNA,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CM,5862,245,TCGA,MSKCC,Colon adenocarcinoma,IGC,Primary solid Tumor,A,1,Total RNA,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CM,5862,244,TCGA,MSKCC,Colon adenocarcinoma,IGC,Primary solid Tumor,A,1,Total RNA,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CM,5863,246,TCGA,MSKCC,Colon adenocarcinoma,IGC,Primary solid Tumor,A,21,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CM,5863,247,TCGA,MSKCC,Colon adenocarcinoma,IGC,Primary solid Tumor,A,21,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CM,5864,249,TCGA,MSKCC,Colon adenocarcinoma,IGC,Primary solid Tumor,A,1,Total RNA,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CM,5864,248,TCGA,MSKCC,Colon adenocarcinoma,IGC,Primary solid Tumor,A,1,Total RNA,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CM,5868,250,TCGA,MSKCC,Colon adenocarcinoma,IGC,Primary solid Tumor,A,1,Total RNA,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CM,5868,251,TCGA,MSKCC,Colon adenocarcinoma,IGC,Primary solid Tumor,A,1,Total RNA,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AD,5900,116,TCGA,International Genomics Consortium,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AD,5900,117,TCGA,International Genomics Consortium,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CK,5912,213,TCGA,Harvard,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CK,5912,212,TCGA,Harvard,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CK,5913,214,TCGA,Harvard,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CK,5913,215,TCGA,Harvard,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CK,5914,216,TCGA,Harvard,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CK,5914,217,TCGA,Harvard,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CK,5915,218,TCGA,Harvard,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CK,5915,219,TCGA,Harvard,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CK,5916,220,TCGA,Harvard,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CK,5916,221,TCGA,Harvard,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AU,6004,147,TCGA,St. Joseph's Medical Center-(MD),Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AU,6004,146,TCGA,St. Joseph's Medical Center-(MD),Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,A6,6137,49,TCGA,Christiana Healthcare,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1773,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,A6,6137,50,TCGA,Christiana Healthcare,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1773,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,A6,6138,52,TCGA,Christiana Healthcare,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1773,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,A6,6138,51,TCGA,Christiana Healthcare,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1773,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,A6,6140,53,TCGA,Christiana Healthcare,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1773,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,A6,6140,54,TCGA,Christiana Healthcare,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1773,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,A6,6141,55,TCGA,Christiana Healthcare,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1773,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,A6,6141,56,TCGA,Christiana Healthcare,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1773,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,A6,6142,57,TCGA,Christiana Healthcare,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1773,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,A6,6142,58,TCGA,Christiana Healthcare,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1773,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CM,6161,253,TCGA,MSKCC,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CM,6161,252,TCGA,MSKCC,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CM,6162,254,TCGA,MSKCC,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CM,6162,255,TCGA,MSKCC,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CM,6163,256,TCGA,MSKCC,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CM,6163,257,TCGA,MSKCC,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CM,6164,258,TCGA,MSKCC,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CM,6164,259,TCGA,MSKCC,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CM,6165,260,TCGA,MSKCC,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CM,6165,261,TCGA,MSKCC,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CM,6166,262,TCGA,MSKCC,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CM,6166,263,TCGA,MSKCC,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CM,6167,264,TCGA,MSKCC,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CM,6167,265,TCGA,MSKCC,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CM,6168,267,TCGA,MSKCC,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CM,6168,266,TCGA,MSKCC,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CM,6169,269,TCGA,MSKCC,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CM,6169,268,TCGA,MSKCC,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CM,6170,270,TCGA,MSKCC,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CM,6170,271,TCGA,MSKCC,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CM,6171,273,TCGA,MSKCC,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CM,6171,272,TCGA,MSKCC,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CM,6172,274,TCGA,MSKCC,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CM,6172,275,TCGA,MSKCC,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1652,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AY,6196,150,TCGA,UNC,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AY,6196,151,TCGA,UNC,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AY,6197,152,TCGA,UNC,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AY,6197,153,TCGA,UNC,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,G4,6293,434,TCGA,Roswell Park,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,G4,6293,435,TCGA,Roswell Park,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,G4,6294,436,TCGA,Roswell Park,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1773,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,G4,6294,437,TCGA,Roswell Park,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1773,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,G4,6295,438,TCGA,Roswell Park,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,G4,6295,439,TCGA,Roswell Park,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,G4,6297,440,TCGA,Roswell Park,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,G4,6297,441,TCGA,Roswell Park,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,G4,6298,443,TCGA,Roswell Park,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,G4,6298,442,TCGA,Roswell Park,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,G4,6299,444,TCGA,Roswell Park,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1773,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,G4,6299,445,TCGA,Roswell Park,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1773,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,G4,6302,447,TCGA,Roswell Park,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,G4,6302,446,TCGA,Roswell Park,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,G4,6303,448,TCGA,Roswell Park,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1773,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,G4,6303,449,TCGA,Roswell Park,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1773,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,G4,6304,451,TCGA,Roswell Park,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1927,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,G4,6304,450,TCGA,Roswell Park,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1927,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,G4,6306,452,TCGA,Roswell Park,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1773,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,G4,6306,453,TCGA,Roswell Park,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1773,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,G4,6307,455,TCGA,Roswell Park,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,G4,6307,454,TCGA,Roswell Park,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,G4,6309,456,TCGA,Roswell Park,Colon adenocarcinoma,IGC,Primary solid Tumor,A,21,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,G4,6309,457,TCGA,Roswell Park,Colon adenocarcinoma,IGC,Primary solid Tumor,A,21,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,G4,6310,458,TCGA,Roswell Park,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,G4,6310,459,TCGA,Roswell Park,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,G4,6311,460,TCGA,Roswell Park,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,G4,6311,461,TCGA,Roswell Park,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,G4,6314,462,TCGA,Roswell Park,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,G4,6314,463,TCGA,Roswell Park,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,G4,6315,464,TCGA,Roswell Park,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,G4,6315,465,TCGA,Roswell Park,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,G4,6317,466,TCGA,Roswell Park,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,G4,6317,467,TCGA,Roswell Park,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,G4,6320,470,TCGA,Roswell Park,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,G4,6320,471,TCGA,Roswell Park,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,G4,6321,472,TCGA,Roswell Park,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,G4,6321,473,TCGA,Roswell Park,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,G4,6322,474,TCGA,Roswell Park,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,G4,6322,475,TCGA,Roswell Park,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,G4,6323,476,TCGA,Roswell Park,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,G4,6323,477,TCGA,Roswell Park,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AY,6386,154,TCGA,UNC,Colon adenocarcinoma,IGC,Primary solid Tumor,A,21,mirVana RNA (Allprep DNA) produced by hybrid protocol,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AY,6386,155,TCGA,UNC,Colon adenocarcinoma,IGC,Primary solid Tumor,A,21,mirVana RNA (Allprep DNA) produced by hybrid protocol,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,F4,6459,403,TCGA,Asterand,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1773,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,F4,6459,402,TCGA,Asterand,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1773,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,F4,6460,404,TCGA,Asterand,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1773,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,F4,6460,405,TCGA,Asterand,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1773,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,F4,6461,407,TCGA,Asterand,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1773,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,F4,6461,406,TCGA,Asterand,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1773,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,F4,6463,408,TCGA,Asterand,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,F4,6463,409,TCGA,Asterand,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,D5,6529,300,TCGA,Greater Poland Cancer Center,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1773,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,D5,6529,301,TCGA,Greater Poland Cancer Center,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1773,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,D5,6530,303,TCGA,Greater Poland Cancer Center,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,D5,6530,302,TCGA,Greater Poland Cancer Center,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,D5,6531,304,TCGA,Greater Poland Cancer Center,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,D5,6531,305,TCGA,Greater Poland Cancer Center,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,D5,6532,307,TCGA,Greater Poland Cancer Center,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,D5,6532,306,TCGA,Greater Poland Cancer Center,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,D5,6533,309,TCGA,Greater Poland Cancer Center,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,D5,6533,308,TCGA,Greater Poland Cancer Center,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,D5,6534,310,TCGA,Greater Poland Cancer Center,Colon adenocarcinoma,IGC,Primary solid Tumor,A,21,mirVana RNA (Allprep DNA) produced by hybrid protocol,1927,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,D5,6534,311,TCGA,Greater Poland Cancer Center,Colon adenocarcinoma,IGC,Primary solid Tumor,A,21,mirVana RNA (Allprep DNA) produced by hybrid protocol,1927,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,D5,6535,313,TCGA,Greater Poland Cancer Center,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,D5,6535,312,TCGA,Greater Poland Cancer Center,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,D5,6536,314,TCGA,Greater Poland Cancer Center,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,D5,6536,315,TCGA,Greater Poland Cancer Center,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,D5,6537,317,TCGA,Greater Poland Cancer Center,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,D5,6537,316,TCGA,Greater Poland Cancer Center,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,D5,6538,318,TCGA,Greater Poland Cancer Center,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,D5,6538,319,TCGA,Greater Poland Cancer Center,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,D5,6539,321,TCGA,Greater Poland Cancer Center,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,D5,6539,320,TCGA,Greater Poland Cancer Center,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,D5,6540,322,TCGA,Greater Poland Cancer Center,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,D5,6540,323,TCGA,Greater Poland Cancer Center,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,D5,6541,324,TCGA,Greater Poland Cancer Center,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,D5,6541,325,TCGA,Greater Poland Cancer Center,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1722,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AD,6548,119,TCGA,International Genomics Consortium,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AD,6548,118,TCGA,International Genomics Consortium,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,F4,6569,411,TCGA,Asterand,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1773,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,F4,6569,410,TCGA,Asterand,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1773,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,F4,6570,412,TCGA,Asterand,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1773,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,F4,6570,413,TCGA,Asterand,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1773,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,G4,6586,478,TCGA,Roswell Park,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1773,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,G4,6586,479,TCGA,Roswell Park,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1773,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,G4,6588,480,TCGA,Roswell Park,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1773,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,G4,6588,481,TCGA,Roswell Park,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1773,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AZ,6598,169,TCGA,University of Pittsburgh,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1773,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AZ,6598,168,TCGA,University of Pittsburgh,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1773,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AZ,6599,170,TCGA,University of Pittsburgh,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1773,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AZ,6599,171,TCGA,University of Pittsburgh,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1773,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AZ,6600,173,TCGA,University of Pittsburgh,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1773,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AZ,6600,172,TCGA,University of Pittsburgh,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1773,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AZ,6601,174,TCGA,University of Pittsburgh,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1773,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AZ,6601,175,TCGA,University of Pittsburgh,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1773,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AZ,6603,176,TCGA,University of Pittsburgh,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AZ,6603,177,TCGA,University of Pittsburgh,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AZ,6605,178,TCGA,University of Pittsburgh,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AZ,6605,179,TCGA,University of Pittsburgh,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AZ,6606,180,TCGA,University of Pittsburgh,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AZ,6606,181,TCGA,University of Pittsburgh,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AZ,6607,182,TCGA,University of Pittsburgh,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AZ,6607,183,TCGA,University of Pittsburgh,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AZ,6608,184,TCGA,University of Pittsburgh,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AZ,6608,185,TCGA,University of Pittsburgh,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,G4,6625,483,TCGA,Roswell Park,Colon adenocarcinoma,IGC,Primary solid Tumor,A,21,mirVana RNA (Allprep DNA) produced by hybrid protocol,1773,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,G4,6625,482,TCGA,Roswell Park,Colon adenocarcinoma,IGC,Primary solid Tumor,A,21,mirVana RNA (Allprep DNA) produced by hybrid protocol,1773,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,G4,6626,484,TCGA,Roswell Park,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1773,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,G4,6626,485,TCGA,Roswell Park,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1773,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,G4,6627,487,TCGA,Roswell Park,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1773,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,G4,6627,486,TCGA,Roswell Park,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1773,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,G4,6628,488,TCGA,Roswell Park,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,G4,6628,489,TCGA,Roswell Park,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,A6,6648,59,TCGA,Christiana Healthcare,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1773,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,A6,6648,60,TCGA,Christiana Healthcare,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1773,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,A6,6649,61,TCGA,Christiana Healthcare,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1773,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,A6,6649,62,TCGA,Christiana Healthcare,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1773,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,A6,6650,63,TCGA,Christiana Healthcare,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1773,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,A6,6650,65,TCGA,Christiana Healthcare,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,A279,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,A6,6650,66,TCGA,Christiana Healthcare,Colon adenocarcinoma,IGC,Primary solid Tumor,B,2,RNA,A27D,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,A6,6650,64,TCGA,Christiana Healthcare,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1773,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,A6,6651,67,TCGA,Christiana Healthcare,Colon adenocarcinoma,IGC,Primary solid Tumor,A,21,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,A6,6651,68,TCGA,Christiana Healthcare,Colon adenocarcinoma,IGC,Primary solid Tumor,A,21,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,A6,6652,69,TCGA,Christiana Healthcare,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1773,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,A6,6652,70,TCGA,Christiana Healthcare,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1773,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,A6,6653,71,TCGA,Christiana Healthcare,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1773,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,A6,6653,72,TCGA,Christiana Healthcare,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1773,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,A6,6654,73,TCGA,Christiana Healthcare,Colon adenocarcinoma,IGC,Primary solid Tumor,A,21,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,A6,6654,74,TCGA,Christiana Healthcare,Colon adenocarcinoma,IGC,Primary solid Tumor,A,21,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CM,6674,277,TCGA,MSKCC,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CM,6674,276,TCGA,MSKCC,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CM,6675,278,TCGA,MSKCC,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CM,6675,279,TCGA,MSKCC,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CM,6676,281,TCGA,MSKCC,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CM,6676,280,TCGA,MSKCC,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CM,6677,282,TCGA,MSKCC,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CM,6677,283,TCGA,MSKCC,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CM,6678,284,TCGA,MSKCC,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CM,6678,285,TCGA,MSKCC,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CM,6679,286,TCGA,MSKCC,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CM,6679,287,TCGA,MSKCC,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CM,6680,288,TCGA,MSKCC,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CM,6680,289,TCGA,MSKCC,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,F4,6703,415,TCGA,Asterand,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,F4,6703,414,TCGA,Asterand,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,F4,6704,416,TCGA,Asterand,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,F4,6704,417,TCGA,Asterand,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CA,6715,194,TCGA,ILSBio,Colon adenocarcinoma,IGC,Primary solid Tumor,A,21,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CA,6715,195,TCGA,ILSBio,Colon adenocarcinoma,IGC,Primary solid Tumor,A,21,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CA,6716,196,TCGA,ILSBio,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CA,6716,197,TCGA,ILSBio,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CA,6717,198,TCGA,ILSBio,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CA,6717,199,TCGA,ILSBio,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CA,6718,201,TCGA,ILSBio,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CA,6718,200,TCGA,ILSBio,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CA,6719,202,TCGA,ILSBio,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CA,6719,203,TCGA,ILSBio,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CK,6746,222,TCGA,Harvard,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CK,6746,223,TCGA,Harvard,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CK,6747,224,TCGA,Harvard,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CK,6747,225,TCGA,Harvard,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CK,6748,227,TCGA,Harvard,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CK,6748,226,TCGA,Harvard,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CK,6751,228,TCGA,Harvard,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,CK,6751,229,TCGA,Harvard,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,A6,6780,75,TCGA,Christiana Healthcare,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,A6,6780,76,TCGA,Christiana Healthcare,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,A6,6780,77,TCGA,Christiana Healthcare,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,A279,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,A6,6780,78,TCGA,Christiana Healthcare,Colon adenocarcinoma,IGC,Primary solid Tumor,B,4,RNA,A27D,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,A6,6781,80,TCGA,Christiana Healthcare,Colon adenocarcinoma,IGC,Primary solid Tumor,A,22,mirVana RNA (Allprep DNA) produced by hybrid protocol,1927,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,A6,6781,81,TCGA,Christiana Healthcare,Colon adenocarcinoma,IGC,Primary solid Tumor,A,22,mirVana RNA (Allprep DNA) produced by hybrid protocol,A279,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,A6,6781,82,TCGA,Christiana Healthcare,Colon adenocarcinoma,IGC,Primary solid Tumor,B,6,RNA,A27D,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,A6,6781,79,TCGA,Christiana Healthcare,Colon adenocarcinoma,IGC,Primary solid Tumor,A,22,mirVana RNA (Allprep DNA) produced by hybrid protocol,1927,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,A6,6782,84,TCGA,Christiana Healthcare,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,A6,6782,83,TCGA,Christiana Healthcare,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,F4,6805,418,TCGA,Asterand,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,F4,6805,419,TCGA,Asterand,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,F4,6806,420,TCGA,Asterand,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,F4,6806,421,TCGA,Asterand,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,F4,6807,422,TCGA,Asterand,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,F4,6807,423,TCGA,Asterand,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,F4,6808,424,TCGA,Asterand,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,F4,6808,425,TCGA,Asterand,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,F4,6809,426,TCGA,Asterand,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,F4,6809,427,TCGA,Asterand,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1838,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,F4,6854,429,TCGA,Asterand,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1927,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,F4,6854,428,TCGA,Asterand,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1927,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,F4,6855,430,TCGA,Asterand,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1927,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,F4,6855,431,TCGA,Asterand,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1927,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,F4,6856,432,TCGA,Asterand,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1927,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,F4,6856,433,TCGA,Asterand,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1927,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AD,6888,120,TCGA,International Genomics Consortium,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1927,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AD,6888,121,TCGA,International Genomics Consortium,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1927,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AD,6889,122,TCGA,International Genomics Consortium,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1927,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AD,6889,123,TCGA,International Genomics Consortium,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1927,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AD,6890,124,TCGA,International Genomics Consortium,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1927,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AD,6890,125,TCGA,International Genomics Consortium,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1927,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AD,6895,126,TCGA,International Genomics Consortium,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1927,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AD,6895,127,TCGA,International Genomics Consortium,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1927,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,D5,6898,326,TCGA,Greater Poland Cancer Center,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1927,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,D5,6898,327,TCGA,Greater Poland Cancer Center,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1927,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AD,6899,128,TCGA,International Genomics Consortium,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1927,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AD,6899,129,TCGA,International Genomics Consortium,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1927,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AD,6901,130,TCGA,International Genomics Consortium,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1927,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AD,6901,131,TCGA,International Genomics Consortium,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1927,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,D5,6920,328,TCGA,Greater Poland Cancer Center,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1927,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,D5,6920,329,TCGA,Greater Poland Cancer Center,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1927,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,D5,6922,330,TCGA,Greater Poland Cancer Center,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1927,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,D5,6922,331,TCGA,Greater Poland Cancer Center,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1927,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,D5,6923,332,TCGA,Greater Poland Cancer Center,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1927,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,D5,6923,333,TCGA,Greater Poland Cancer Center,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1927,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,D5,6924,335,TCGA,Greater Poland Cancer Center,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1927,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,D5,6924,334,TCGA,Greater Poland Cancer Center,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1927,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,D5,6926,336,TCGA,Greater Poland Cancer Center,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1927,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,D5,6926,337,TCGA,Greater Poland Cancer Center,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1927,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,D5,6927,339,TCGA,Greater Poland Cancer Center,Colon adenocarcinoma,IGC,Primary solid Tumor,A,21,mirVana RNA (Allprep DNA) produced by hybrid protocol,1927,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,D5,6927,338,TCGA,Greater Poland Cancer Center,Colon adenocarcinoma,IGC,Primary solid Tumor,A,21,mirVana RNA (Allprep DNA) produced by hybrid protocol,1927,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,D5,6928,340,TCGA,Greater Poland Cancer Center,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1927,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,D5,6928,341,TCGA,Greater Poland Cancer Center,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1927,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,D5,6929,343,TCGA,Greater Poland Cancer Center,Colon adenocarcinoma,IGC,Primary solid Tumor,A,31,mirVana RNA (Allprep DNA) produced by hybrid protocol,1927,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,D5,6929,342,TCGA,Greater Poland Cancer Center,Colon adenocarcinoma,IGC,Primary solid Tumor,A,31,mirVana RNA (Allprep DNA) produced by hybrid protocol,1927,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,D5,6930,344,TCGA,Greater Poland Cancer Center,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1927,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,D5,6930,345,TCGA,Greater Poland Cancer Center,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1927,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,D5,6931,347,TCGA,Greater Poland Cancer Center,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1927,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,D5,6931,346,TCGA,Greater Poland Cancer Center,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1927,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,D5,6932,349,TCGA,Greater Poland Cancer Center,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1927,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,D5,6932,348,TCGA,Greater Poland Cancer Center,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1927,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AD,6963,133,TCGA,International Genomics Consortium,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1927,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AD,6963,132,TCGA,International Genomics Consortium,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1927,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AD,6964,134,TCGA,International Genomics Consortium,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1927,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AD,6964,135,TCGA,International Genomics Consortium,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1927,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AD,6965,137,TCGA,International Genomics Consortium,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1927,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AD,6965,136,TCGA,International Genomics Consortium,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1927,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,D5,7000,350,TCGA,Greater Poland Cancer Center,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1927,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,D5,7000,351,TCGA,Greater Poland Cancer Center,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,1927,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,DM,A0X9,353,TCGA,University Of Michigan,Colon adenocarcinoma,NCH,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,A154,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,DM,A0X9,352,TCGA,University Of Michigan,Colon adenocarcinoma,NCH,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,A154,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,DM,A0XD,354,TCGA,University Of Michigan,Colon adenocarcinoma,NCH,Primary solid Tumor,A,12,mirVana RNA (Allprep DNA) produced by hybrid protocol,A154,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,DM,A0XD,355,TCGA,University Of Michigan,Colon adenocarcinoma,NCH,Primary solid Tumor,A,12,mirVana RNA (Allprep DNA) produced by hybrid protocol,A154,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,DM,A0XF,357,TCGA,University Of Michigan,Colon adenocarcinoma,NCH,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,A154,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,DM,A0XF,356,TCGA,University Of Michigan,Colon adenocarcinoma,NCH,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,A154,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,DM,A1D0,358,TCGA,University Of Michigan,Colon adenocarcinoma,NCH,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,A154,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,DM,A1D0,359,TCGA,University Of Michigan,Colon adenocarcinoma,NCH,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,A154,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,DM,A1D4,361,TCGA,University Of Michigan,Colon adenocarcinoma,NCH,Primary solid Tumor,A,21,mirVana RNA (Allprep DNA) produced by hybrid protocol,A154,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,DM,A1D4,360,TCGA,University Of Michigan,Colon adenocarcinoma,NCH,Primary solid Tumor,A,21,mirVana RNA (Allprep DNA) produced by hybrid protocol,A154,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,DM,A1D6,362,TCGA,University Of Michigan,Colon adenocarcinoma,NCH,Primary solid Tumor,A,21,mirVana RNA (Allprep DNA) produced by hybrid protocol,A154,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,DM,A1D6,363,TCGA,University Of Michigan,Colon adenocarcinoma,NCH,Primary solid Tumor,A,21,mirVana RNA (Allprep DNA) produced by hybrid protocol,A154,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,DM,A1D7,364,TCGA,University Of Michigan,Colon adenocarcinoma,NCH,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,A154,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,DM,A1D7,365,TCGA,University Of Michigan,Colon adenocarcinoma,NCH,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,A154,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,DM,A1D8,366,TCGA,University Of Michigan,Colon adenocarcinoma,NCH,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,A154,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,DM,A1D8,367,TCGA,University Of Michigan,Colon adenocarcinoma,NCH,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,A154,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,DM,A1D9,368,TCGA,University Of Michigan,Colon adenocarcinoma,NCH,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,A154,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,DM,A1D9,369,TCGA,University Of Michigan,Colon adenocarcinoma,NCH,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,A154,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,DM,A1DA,370,TCGA,University Of Michigan,Colon adenocarcinoma,NCH,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,A154,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,DM,A1DA,371,TCGA,University Of Michigan,Colon adenocarcinoma,NCH,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,A154,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,DM,A1DB,372,TCGA,University Of Michigan,Colon adenocarcinoma,NCH,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,A154,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,DM,A1DB,373,TCGA,University Of Michigan,Colon adenocarcinoma,NCH,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,A154,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,DM,A1HA,375,TCGA,University Of Michigan,Colon adenocarcinoma,NCH,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,A154,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,DM,A1HA,374,TCGA,University Of Michigan,Colon adenocarcinoma,NCH,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,A154,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,DM,A1HB,376,TCGA,University Of Michigan,Colon adenocarcinoma,NCH,Primary solid Tumor,A,21,mirVana RNA (Allprep DNA) produced by hybrid protocol,A17X,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,DM,A1HB,377,TCGA,University Of Michigan,Colon adenocarcinoma,NCH,Primary solid Tumor,A,21,mirVana RNA (Allprep DNA) produced by hybrid protocol,A17X,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,DM,A280,379,TCGA,University Of Michigan,Colon adenocarcinoma,NCH,Primary solid Tumor,A,12,mirVana RNA (Allprep DNA) produced by hybrid protocol,A16S,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,DM,A280,378,TCGA,University Of Michigan,Colon adenocarcinoma,NCH,Primary solid Tumor,A,12,mirVana RNA (Allprep DNA) produced by hybrid protocol,A16S,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,DM,A282,380,TCGA,University Of Michigan,Colon adenocarcinoma,NCH,Primary solid Tumor,A,12,mirVana RNA (Allprep DNA) produced by hybrid protocol,A16S,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,DM,A282,381,TCGA,University Of Michigan,Colon adenocarcinoma,NCH,Primary solid Tumor,A,12,mirVana RNA (Allprep DNA) produced by hybrid protocol,A16S,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,DM,A285,383,TCGA,University Of Michigan,Colon adenocarcinoma,NCH,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,A16S,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,DM,A285,382,TCGA,University Of Michigan,Colon adenocarcinoma,NCH,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,A16S,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,DM,A288,384,TCGA,University Of Michigan,Colon adenocarcinoma,NCH,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,A16S,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,DM,A288,385,TCGA,University Of Michigan,Colon adenocarcinoma,NCH,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,A16S,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,DM,A28A,387,TCGA,University Of Michigan,Colon adenocarcinoma,NCH,Primary solid Tumor,A,21,mirVana RNA (Allprep DNA) produced by hybrid protocol,A16S,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,DM,A28A,386,TCGA,University Of Michigan,Colon adenocarcinoma,NCH,Primary solid Tumor,A,21,mirVana RNA (Allprep DNA) produced by hybrid protocol,A16S,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,DM,A28C,389,TCGA,University Of Michigan,Colon adenocarcinoma,NCH,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,A16S,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,DM,A28C,388,TCGA,University Of Michigan,Colon adenocarcinoma,NCH,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,A16S,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,DM,A28E,390,TCGA,University Of Michigan,Colon adenocarcinoma,NCH,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,A16S,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,DM,A28E,391,TCGA,University Of Michigan,Colon adenocarcinoma,NCH,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,A16S,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,DM,A28F,392,TCGA,University Of Michigan,Colon adenocarcinoma,NCH,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,A16S,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,DM,A28F,393,TCGA,University Of Michigan,Colon adenocarcinoma,NCH,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,A16S,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,DM,A28G,394,TCGA,University Of Michigan,Colon adenocarcinoma,NCH,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,A16S,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,DM,A28G,395,TCGA,University Of Michigan,Colon adenocarcinoma,NCH,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,A16S,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,DM,A28H,396,TCGA,University Of Michigan,Colon adenocarcinoma,NCH,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,A16S,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,DM,A28H,397,TCGA,University Of Michigan,Colon adenocarcinoma,NCH,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,A16S,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,DM,A28K,398,TCGA,University Of Michigan,Colon adenocarcinoma,NCH,Primary solid Tumor,A,21,mirVana RNA (Allprep DNA) produced by hybrid protocol,A16S,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,DM,A28K,399,TCGA,University Of Michigan,Colon adenocarcinoma,NCH,Primary solid Tumor,A,21,mirVana RNA (Allprep DNA) produced by hybrid protocol,A16S,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,DM,A28M,400,TCGA,University Of Michigan,Colon adenocarcinoma,NCH,Primary solid Tumor,A,12,mirVana RNA (Allprep DNA) produced by hybrid protocol,A16S,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,DM,A28M,401,TCGA,University Of Michigan,Colon adenocarcinoma,NCH,Primary solid Tumor,A,12,mirVana RNA (Allprep DNA) produced by hybrid protocol,A16S,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,NH,A50T,490,TCGA,Candler,Colon adenocarcinoma,NCH,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,A28I,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,NH,A50U,491,TCGA,Candler,Colon adenocarcinoma,NCH,Primary solid Tumor,A,33,mirVana RNA (Allprep DNA) produced by hybrid protocol,A37P,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,NH,A50V,492,TCGA,Candler,Colon adenocarcinoma,NCH,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,A28I,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AY,A54L,156,TCGA,UNC,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,A28I,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,A6,A565,85,TCGA,Christiana Healthcare,Colon adenocarcinoma,IGC,Primary solid Tumor,A,31,mirVana RNA (Allprep DNA) produced by hybrid protocol,A28I,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,A6,A566,86,TCGA,Christiana Healthcare,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,A28I,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,A6,A567,87,TCGA,Christiana Healthcare,Colon adenocarcinoma,IGC,Primary solid Tumor,A,31,mirVana RNA (Allprep DNA) produced by hybrid protocol,A28I,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,A6,A56B,88,TCGA,Christiana Healthcare,Colon adenocarcinoma,IGC,Primary solid Tumor,A,31,mirVana RNA (Allprep DNA) produced by hybrid protocol,A28I,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AD,A5EJ,138,TCGA,International Genomics Consortium,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,A28I,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AD,A5EK,139,TCGA,International Genomics Consortium,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,A28I,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,NH,A5IV,493,TCGA,Candler,Colon adenocarcinoma,NCH,Primary solid Tumor,A,42,mirVana RNA (Allprep DNA) produced by hybrid protocol,A37P,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,QG,A5YV,500,TCGA,BLN - Baylor,Colon adenocarcinoma,NCH,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,A28I,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,QG,A5YW,501,TCGA,BLN - Baylor,Colon adenocarcinoma,NCH,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,A28I,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,QG,A5YX,502,TCGA,BLN - Baylor,Colon adenocarcinoma,NCH,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,A28I,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,QG,A5Z1,503,TCGA,BLN - Baylor,Colon adenocarcinoma,NCH,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,A28I,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,QG,A5Z2,504,TCGA,BLN - Baylor,Colon adenocarcinoma,NCH,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,A28I,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,A6,A5ZU,89,TCGA,Christiana Healthcare,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,A28I,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AY,A69D,157,TCGA,UNC,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,A37P,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,NH,A6GA,494,TCGA,Candler,Colon adenocarcinoma,NCH,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,A37P,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,NH,A6GB,495,TCGA,Candler,Colon adenocarcinoma,NCH,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,A37P,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,NH,A6GC,496,TCGA,Candler,Colon adenocarcinoma,NCH,Primary solid Tumor,A,12,mirVana RNA (Allprep DNA) produced by hybrid protocol,A41D,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AY,A71X,158,TCGA,UNC,Colon adenocarcinoma,IGC,Primary solid Tumor,A,12,mirVana RNA (Allprep DNA) produced by hybrid protocol,A37P,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,NH,A8F7,497,TCGA,Candler,Colon adenocarcinoma,NCH,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,A41D,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,NH,A8F8,499,TCGA,Candler,Colon adenocarcinoma,NCH,Primary solid Tumor,A,72,mirVana RNA (Allprep DNA) produced by hybrid protocol,A41D,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,RU,A8FL,506,TCGA,Northwestern University,Colon adenocarcinoma,NCH,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,A37P,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,AY,A8YK,159,TCGA,UNC,Colon adenocarcinoma,IGC,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,A41D,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,T9,A92H,508,TCGA,Molecular Response,Colon adenocarcinoma,NCH,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,A37P,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,4N,A93T,2,TCGA,Mary Bird Perkins Cancer Center - Our Lady of the Lake,Colon adenocarcinoma,NCH,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,A37P,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,QL,A97D,505,TCGA, University of Chicago,Colon adenocarcinoma,NCH,Primary solid Tumor,A,12,mirVana RNA (Allprep DNA) produced by hybrid protocol,A41D,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,3L,AA1B,1,TCGA,Albert Einstein Medical Center,Colon adenocarcinoma,NCH,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,A37P,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,4T,AA8H,3,TCGA,Duke University,Colon adenocarcinoma,NCH,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,A41D,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,5M,AAT4,4,TCGA,University of Sao Paulo,Colon adenocarcinoma,NCH,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,A41D,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,5M,AAT6,6,TCGA,University of Sao Paulo,Colon adenocarcinoma,NCH,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,A41D,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,5M,AATE,8,TCGA,University of Sao Paulo,Colon adenocarcinoma,NCH,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,A41D,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization CenterTCGA,WS,AB45,509,TCGA,University of Kansas,Colon adenocarcinoma,NCH,Primary solid Tumor,A,11,mirVana RNA (Allprep DNA) produced by hybrid protocol,A41D,Canada's Michael Smith Genome Sciences Centre,Cancer Genomic Characterization Center